Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human T(H) cell lines following stimulation with RS virus and RS virus proteins

Journal of Medical Virology

Volumn 49, Issue 3, 1996, Pages 161-169

  Jackson, Margaret ^a,b   Scott, Ron ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

T cell immunity; T(H)1 and T(H)2 subsets; viral protein recognition

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE;

ADULT; ANTIGENS, VIRAL; CELL LINE; CYTOKINES; FEMALE; HN PROTEIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0029779894     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199607)49:3<161::AID-JMV2>3.0.CO;2-2     Document Type: Article

References (33)

1. Allison AC, Byars NE (1991): Immunological adjuvants: desirable properties and side-effects. Molecular Immunology 28:279-284.
2. Alwan WH, Record FM, Openshaw PJM (1993): Phenotypic and functional characterisation of T cell lines specific for individual respiratory syncytial virus proteins. Journal of Immunology 150:5211-5218.
3. Alwan WH, Kozlowska WJ, Openshaw PJM (1994): Distinct types of lung disease caused by functional subsets of antiviral cells. Journal of Experimental Medicine 179:81-89.
4. Anderson JJ, Harrop JA, Peers H, Briggs H, Toms GL, Scott R (1991): Recognition of respiratory syncytial virus proteins by human and BALB/c lymphocytes. Journal of Medical Virology 35:165-173.
5. + T lymphocyte lines. Immunology of Infectious Diseases 3:346-349.
6. Anderson LJ, Tsou C, Potter C, Keyserling HL, Smith TF, Ananaba G, Bangham CRM (1994): Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. Journal of Infectious Diseases 170:1201-1208.
7. Bright H, Turnbull TJB, Toms GL, Scott R (1995): Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion and its fusion protein in BALB/c mice. Vaccine 13:915-922.
8. Cherrie AH, Anderson K, Wertz GW, Openshaw PJM (1992): Human cytotoxic T cells stimulated by antigen on dendritic cells recognise the N, SH, F, 22K and 1b proteins of respiratory syncytial virus. Journal of Virology 66:2102-2110.
9. H2 switch is a critical step in the etiology of HIV infection. Immunology Today 14:107-111.
10. + T cells. Journal of Virology 66:7444-7451.
11. Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC, Murphy BR (1994): Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV immunised BALB/c mice is abrogated by depletion of interleukin (IL-4) and IL-10. Journal of Virology 68:5321-5325.
12. H2) T cell clones and inhibits their antigen specific proliferation and cytokine production. Journal of Immunology 150:353-360.
13. Frigas E, Gleich J (1986): The eosinophil and the pathophysiology of asthma. Journal of Allergy and Clinical Immunology 77:527-537.
14. Gharpure NA, Wright PF, Chanock RM (1969): Temperature sensitive mutants of respiratory syncytial virus infection. Journal of Virology 3:414-421.
15. Gillis S, Smith KA (1977): Long term culture of tumour specific cytotoxic T cells dependent upon IL-2. Nature 268:154-156.
16. Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT (1991a): Respiratory syncytial virus infection in anti-μ treated mice. Journal of Virology 65:4936-4942.
17. Graham BS, Bunton LA, Wright PF, Karzon DT (1991b): Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. Journal of Clinical Investigation 88:1026-1033.
18. Graham BS, Henderson GS, Tang Y-W, Lu X, Neuzil KM, Colley DG (1993): Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. Journal of Immunology 151:2032-2040.
19. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989): Reciprocal expression of interferon-γ and interleukin-4 during the resolution or progression of murine leishmaniasis. Journal of Experimental Medicine 169:59-72.
20. Henderson FW, Collier AM, Clyde WA, Denny FW (1979): Respiratory syncytial viral infection, reinfections and immunity: a prospective longitudinal study in young children. New England Journal of Medicine 300:530-534.
21. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE (1969): An epidemiological study of altered clinical reactivity to respiratory syncytial virus infection in children previously vaccinated with an inactivated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:405-421.
22. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH (1969): Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422-434.
23. Levely ME, Bannow CA, Smith CW, Nicholas JA (1991): Immunodominant T cell epitope on the F protein of respiratory syncytial virus recognised by human lymphocytes. Journal of Virology 65: 3789-3796.
24. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7:145-173.
25. Openshaw PJM, Clarke SL, Record FM (1992): Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. International Immunology 4:493-500.
26. H2-like bronchoalveolar T-lymphocyte populations in atopic asthma. New England Journal of Medicine 326:298-304.
27. H2 subsets: doubt no more. Immunology Today 12:256-257.
28. Routledge EG, Willcocks MM, Samson ACR, Morgan L, Scott R, Anderson JJ, Toms GL (1988): The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. Journal of General Virology 69:293-303.
29. H2 cells in a rodent malaria infection. Science 260:1931-1934.
30. H2 response. Clinical Immunology and Immunopathology 67:171-177.
31. Welliver RC, Kaul A, Ogra PL (1979): Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. Journal of Pediatrics 94:370-375.
32. Wright PF, Belshe RB, Kim HW, Van Vorris LP, Chanock RM (1982): Administration of a highly attenuated live respiratory syncytial virus vaccine to adults and children. Infection and Immunity 37:397-401.
33. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991): Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254:277-279.